Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtre
1.
The Korean Journal of Parasitology ; : 623-630, 2017.
Article Dans Anglais | WPRIM | ID: wpr-16098

Résumé

Plasmodium lactate dehydrogenase (pLDH) is a strong target antigen for the determination of infection with Plasmodium species specifically. However, a more effective antibody is needed because of the low sensitivity of the current antibody in many immunological diagnostic assays. In this study, recombinant Plasmodium vivax LDH (PvLDH) was experimentally constructed and expressed as a native antigen to develop an effective P. vivax-specific monoclonal antibody (mAb). Two mAbs (2CF5 and 1G10) were tested using ELISA and immunofluorescence assays (IFA), as both demonstrated reactivity against pLDH antigen. Of the 2 antibodies, 2CF5 was not able to detect P. falciparum, suggesting that it might possess P. vivax-specificity. The detection limit for a pair of 2 mAbs-linked sandwich ELISA was 31.3 ng/ml of the recombinant antigen. The P. vivax-specific performance of mAbs-linked ELISA was confirmed by in vitro-cultured P. falciparum and P. vivax-infected patient blood samples. In conclusion, the 2 new antibodies possessed the potential to detect P. vivax and will be useful in immunoassay.


Sujets)
Humains , Anticorps , Anticorps monoclonaux , Diagnostic , Test ELISA , Technique d'immunofluorescence , Dosage immunologique , L-Lactate dehydrogenase , Limite de détection , Plasmodium vivax , Plasmodium
2.
The Korean Journal of Parasitology ; : 155-161, 2016.
Article Dans Anglais | WPRIM | ID: wpr-57436

Résumé

Toxoplasma gondii is an important opportunistic pathogen that causes toxoplasmosis, which has very few therapeutic treatment options. The most effective therapy is a combination of pyrimethamine and sulfadiazine; however, their utility is limited because of drug toxicity and serious side effects. For these reasons, new drugs with lower toxicity are urgently needed. In this study, the compound, (Z)-1-[(5-nitrofuran-2-yl)methyleneamino]-imidazolidine-2,4-dione (nitrofurantoin), showed anti-T. gondii effects in vitro and in vivo. In HeLa cells, the selectivity of nitrofurantoin was 2.3, which was greater than that of pyrimethamine (0.9). In T. gondii-infected female ICR mice, the inhibition rate of T. gondii growth in the peritoneal cavity was 44.7% compared to the negative control group after 4-day treatment with 100 mg/kg of nitrofurantoin. In addition, hematology indicators showed that T. gondii infection-induced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, biochemical parameters involved in liver injury, were reduced by nitrofurantoin significantly. Moreover, nitrofurantoin exerted significant effects on the index of antioxidant status, i.e., malondialdehyde (MDA) and glutathione (GSH). The nitrofurantoin-treated group inhibited the T. gondii-induced MDA levels while alleviating the decrease in GSH levels. Thus, nitrofurantoin is a potential anti-T. gondii candidate for clinical application.


Sujets)
Animaux , Femelle , Humains , Souris , Alanine transaminase , Aspartate aminotransferases , Effets secondaires indésirables des médicaments , Glutathion , Cellules HeLa , Hématologie , Foie , Malonaldéhyde , Souris de lignée ICR , Nitrofurantoïne , Cavité péritonéale , Pyriméthamine , Sulfadiazine , Toxoplasma , Toxoplasmose
3.
The Korean Journal of Parasitology ; : 665-673, 2015.
Article Dans Anglais | WPRIM | ID: wpr-9589

Résumé

After invasion of red blood cells, malaria matures within the cell by degrading hemoglobin avidly. For enormous protein breakdown in trophozoite stage, many efficient and ordered proteolysis networks have been postulated and exploited. In this study, a potential interaction of a 60-kDa Plasmodium falciparum (Pf)-heat shock protein (Hsp60) and Pf-calpain, a cysteine protease, was explored. Pf-infected RBC was isolated and the endogenous Pf-Hsp60 and Pf-calpain were determined by western blot analysis and similar antigenicity of GroEL and Pf-Hsp60 was determined with anti-Pf-Hsp60. Potential interaction of Pf-calpain and Pf-Hsp60 was determined by immunoprecipitation and immunofluorescence assay. Mizoribine, a well-known inhibitor of Hsp60, attenuated both Pf-calpain enzyme activity as well as P. falciparum growth. The presented data suggest that the Pf-Hsp60 may function on Pf-calpain in a part of networks during malaria growth.


Sujets)
Humains , Séquence d'acides aminés , Calpain/génétique , Chaperonine-60/composition chimique , Érythrocytes/parasitologie , Paludisme à Plasmodium falciparum/parasitologie , Données de séquences moléculaires , Plasmodium falciparum/composition chimique , Liaison aux protéines , Protéines de protozoaire/composition chimique , Alignement de séquences
4.
Journal of Korean Medical Science ; : 672-679, 2013.
Article Dans Anglais | WPRIM | ID: wpr-65460

Résumé

Diagnosis of scrub typhus is difficult because its symptoms are very similar to other acute febrile illnesses, such as leptospirosis, murine typhus, and other viral hemorrhagic fevers. To differentiate scrub typhus from other acute febrile diseases, a rapid and reliable serological diagnosis is important. We have developed a chimeric recombinant antigen cr56 and two other recombinant antigens, r21 and kr56, from various serotypes of Orientia tsutsugamushi. They were tested for the detection of antibodies against O. tsutsugamushi in the patient's serum samples using enzyme-linked immunosorbent assay (ELISA) and dot-blot analyses. As of conventional immunofluorescence assay (IFA), when the mixture of these three recombinant antigens was used, both sensitivity and specificity of the recombinant antigens were increased up to 98% in IgM and IgG at ELISA and dot blotting. Additionally, both sensitivity and specificity by detection of IgM and IgG antibodies at rapid diagnostic test (RDT), using the mixture of three antigens and gold conjugated antibodies, were 99%. Our results suggest the use of mixture of these recombinant antigen proteins in ELISA or RDT is suitable as a diagnostic test for scrub typhus.


Sujets)
Humains , Anticorps antibactériens/sang , Antigènes bactériens , Test ELISA , Technique d'immunofluorescence indirecte , Or/composition chimique , Dosage immunologique , Immunoglobuline G/sang , Immunoglobuline M/sang , Orientia tsutsugamushi/immunologie , Protéines recombinantes/biosynthèse , Fièvre fluviale du Japon/diagnostic , Sensibilité et spécificité , Sérotypie
5.
Experimental & Molecular Medicine ; : 278-284, 2002.
Article Dans Anglais | WPRIM | ID: wpr-134595

Résumé

Direct injection of the vascular endothelial growth factor (VEGF) gene plasmid DNA into the myocardium was shown to induce development of new blood vessels to increase the circulation in the heart of patients with coronary artery diseases. However, such angiogenic gene therapy (via naked DNA) was limited by low level of gene expression. Furthermore, the temporal and spatial characteristics of VEGF gene transfer in the heart are not known. In this study, we demonstrated that a plasmid vector, containing the human cytomegalovirus immediate early (HCMV IE) promoter and enhancer, induces greater expression of gene in the rat heart monitored by gene fused to the chloramphenicol acetyl transferase (CAT) reporter, than four different viral and cellular promoters. Interestingly, expression of VEGF121 protein showed an earlier peak, a shorter duration, and a wider distribution than that of CAT only. Therefore, a plasmid vector with an HCMV IE promoter/enhancer provides clear advantages over other previously developed plasmids. Furthermore, expression profile of VEGF121 gene may provide useful information in the design of angiogenic gene therapy in the heart


Sujets)
Animaux , Mâle , Rats , Chloramphenicol O-acetyltransferase/analyse , Étude comparative , Cytomegalovirus/génétique , ADN viral/administration et posologie , Facteurs de croissance endothéliale/analyse , Éléments activateurs (génétique) , Régulation de l'expression des gènes viraux , Fusion de gènes , Techniques de transfert de gènes , Gènes viraux , Vecteurs génétiques , Protéines et peptides de signalisation intercellulaire/analyse , Lymphokines/analyse , Myocarde/métabolisme , Plasmides/génétique , Régions promotrices (génétique) , Rat Sprague-Dawley , Facteurs temps , Facteur de croissance endothéliale vasculaire de type A , Facteurs de croissance endothéliale vasculaire
6.
Experimental & Molecular Medicine ; : 278-284, 2002.
Article Dans Anglais | WPRIM | ID: wpr-134594

Résumé

Direct injection of the vascular endothelial growth factor (VEGF) gene plasmid DNA into the myocardium was shown to induce development of new blood vessels to increase the circulation in the heart of patients with coronary artery diseases. However, such angiogenic gene therapy (via naked DNA) was limited by low level of gene expression. Furthermore, the temporal and spatial characteristics of VEGF gene transfer in the heart are not known. In this study, we demonstrated that a plasmid vector, containing the human cytomegalovirus immediate early (HCMV IE) promoter and enhancer, induces greater expression of gene in the rat heart monitored by gene fused to the chloramphenicol acetyl transferase (CAT) reporter, than four different viral and cellular promoters. Interestingly, expression of VEGF121 protein showed an earlier peak, a shorter duration, and a wider distribution than that of CAT only. Therefore, a plasmid vector with an HCMV IE promoter/enhancer provides clear advantages over other previously developed plasmids. Furthermore, expression profile of VEGF121 gene may provide useful information in the design of angiogenic gene therapy in the heart


Sujets)
Animaux , Mâle , Rats , Chloramphenicol O-acetyltransferase/analyse , Étude comparative , Cytomegalovirus/génétique , ADN viral/administration et posologie , Facteurs de croissance endothéliale/analyse , Éléments activateurs (génétique) , Régulation de l'expression des gènes viraux , Fusion de gènes , Techniques de transfert de gènes , Gènes viraux , Vecteurs génétiques , Protéines et peptides de signalisation intercellulaire/analyse , Lymphokines/analyse , Myocarde/métabolisme , Plasmides/génétique , Régions promotrices (génétique) , Rat Sprague-Dawley , Facteurs temps , Facteur de croissance endothéliale vasculaire de type A , Facteurs de croissance endothéliale vasculaire
SÉLECTION CITATIONS
Détails de la recherche